Serum TLR2 and TLR9 in Prostate Cancer Patients in Relation to EBV Status.
Dominika SikoraJacek KiśEwa StępieńBartłomiej DropMałgorzata Polz-DacewiczPublished in: International journal of molecular sciences (2024)
The relationship between Toll-like receptors (TLRs) and prostate cancer (PCa) is complex due to the presence of the Epstein-Barr virus (EBV) infection, which has been identified as a predisposing factor for some cancers, including PCa. The present study aims to investigate these complex links by examining the levels of selected TLRs and the potential impact of EBV infection on PCa. Therefore, we examined the serum of patients with PCa. The study compared EBV(+) patients to risk groups, the Gleason score (GS), and the T-trait. Additionally, the correlation between TLR and antibody levels was examined. The results indicated that higher levels of TLR-2 and TLR-9 were observed in more advanced PCa. The findings of this study may contribute to a deeper understanding of the role of viral infections in PCa and provide information on future strategies for the diagnosis, prevention, and treatment of these malignancies.
Keyphrases
- epstein barr virus
- prostate cancer
- toll like receptor
- end stage renal disease
- diffuse large b cell lymphoma
- inflammatory response
- immune response
- ejection fraction
- chronic kidney disease
- radical prostatectomy
- newly diagnosed
- peritoneal dialysis
- healthcare
- gene expression
- prognostic factors
- nuclear factor
- sars cov
- patient reported outcomes
- dna methylation
- risk assessment
- current status
- young adults
- smoking cessation
- genome wide association